Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01676805 · ClinicalTrials.gov registry record
Tissue Collection for Studies of Lymph Cancer
A clinical trial of Multiple Myeloma and Lymphoma, Non-Hodgkin, sponsored by National Cancer Institute (NCI).
- Recruiting
- Registry status
- 1,295
- Enrollment target
- 2
- Study locations
NCT01676805 is a study of Multiple Myeloma and Lymphoma, Non-Hodgkin that is actively recruiting participants, run by National Cancer Institute (NCI). The registered enrollment target is 1,295 participants, above the 544-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (138% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT01676805, a study of Multiple Myeloma and Lymphoma, Non-Hodgkin, is actively recruiting participants, sponsored by National Cancer Institute (NCI).
- RECRUITING
- Registry status
- 1,295 participants
- Enrollment target
- 2
- Study locations
Study Summary
Background: \- Lab studies help researchers better understand cancer biology. This information may lead to new methods for diagnosing or treating cancer. To develop these studies, researchers want to collect samples from people with cancer or precancer conditions of the lymph system. These conditions include multiple myeloma, different types of lymphoma, and adult leukemia/lymphoma. The samples collected will include blood, urine, bone marrow, and tumor and skin tissue. Objectives: \- To collect tissue samples to study different types of lymph cancer. Eligibility: \- Individuals at least 18 years of age who have a lymphoid cancer or precancer condition. Design: * Participants will be screened with a physical exam and medical history. * Different samples will be collected for study. Blood samples will be collected at the initial testing. More blood samples will be collected at different treatment points. Other liquid samples include urine, bone marrow, and any abnormal fluid. Tumor tissue and skin tissue biopsies will also be collected for study. * Treatment will not be provided as part of this study.
Conditions Studied
Study Locations (2)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Other
- University of the West Indies - Kingston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,295 participants |
| Start Date | 2012-09-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01676805
The ClinicalTrials.gov registry entry for NCT01676805 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,295 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 544-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (138% higher). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Multiple Myeloma appearing as the primary indexed condition, and to 0 interventions.
NCT01676805 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Other.
Frequently Asked Questions
What is clinical trial NCT01676805 about?
NCT01676805 is a clinical study titled "Tissue Collection for Studies of Lymph Cancer". Background: \- Lab studies help researchers better understand cancer biology. This information may lead to new methods for diagnosing or treating cancer. To develop these studies, researchers want to collect samples from people with cancer or precancer conditions of the lymph system. These conditio...
What is the current status of trial NCT01676805?
This trial is currently recruiting. The enrollment target is 1,295 participants. The study started on 2012-09-21.
What conditions does trial NCT01676805 study?
This clinical trial studies the following conditions: Multiple Myeloma, Lymphoma, Non-Hodgkin, Hodgkin Disease, Leukemia-Lymphoma, Adult T-Cell, Lymphomatoid Granulomatosis.
Who is sponsoring clinical trial NCT01676805?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01676805 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Myeloma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant
RECRUITING · Phase 2
-
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
RECRUITING · Phase 1
-
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
RECRUITING · NA
-
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
RECRUITING
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.